Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design.
Malaina I, Gonzalez-Melero L, Martínez L, Salvador A, Sanchez-Diez A, Asumendi A, Margareto J, Carrasco-Pujante J, Legarreta L, García MA, Pérez-Pinilla MB, Izu R, Martínez de la Fuente I, Igartua M, Alonso S, Hernandez RM, Boyano MD. Malaina I, et al. Among authors: izu r. Int J Mol Sci. 2023 May 19;24(10):9024. doi: 10.3390/ijms24109024. Int J Mol Sci. 2023. PMID: 37240369 Free PMC article.
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.
Ortega-Martínez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortés J, García-Vázquez MD, Pérez-Yarza G, Izu R, Luís Díaz-Ramón J, de la Fuente IM, Asumendi A, Boyano MD. Ortega-Martínez I, et al. Among authors: izu r. Int J Cancer. 2016 Oct 1;139(7):1598-607. doi: 10.1002/ijc.30202. Epub 2016 Jun 11. Int J Cancer. 2016. PMID: 27216146 Free PMC article.
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study.
Mancuso F, Lage S, Rasero J, Díaz-Ramón JL, Apraiz A, Pérez-Yarza G, Ezkurra PA, Penas C, Sánchez-Diez A, García-Vazquez MD, Gardeazabal J, Izu R, Mujika K, Cortés J, Asumendi A, Boyano MD. Mancuso F, et al. Among authors: izu r. Mol Oncol. 2020 Aug;14(8):1705-1718. doi: 10.1002/1878-0261.12732. Epub 2020 Jun 24. Mol Oncol. 2020. PMID: 32485045 Free PMC article.
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis.
Sevilla A, Sánchez-Diez A, Cobo S, Izagirre N, Martinez-Cadenas C, Martí RM, Puértolas T, de Unamuno B, Bañuls J, Izu R, Gardeazabal J, Asumendi A, Boyano MD, Alonso S. Sevilla A, et al. Among authors: izu r. Life (Basel). 2022 Dec 1;12(12):2004. doi: 10.3390/life12122004. Life (Basel). 2022. PMID: 36556369 Free PMC article.
Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients.
Diaz-Ramón JL, Gardeazabal J, Izu RM, Garrote E, Rasero J, Apraiz A, Penas C, Seijo S, Lopez-Saratxaga C, De la Peña PM, Sanchez-Diaz A, Cancho-Galan G, Velasco V, Sevilla A, Fernandez D, Cuenca I, Cortes JM, Alonso S, Asumendi A, Boyano MD. Diaz-Ramón JL, et al. Among authors: izu rm. Cancers (Basel). 2023 Apr 6;15(7):2174. doi: 10.3390/cancers15072174. Cancers (Basel). 2023. PMID: 37046835 Free PMC article.
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementería N, Pérez-Yarza G, Boyano MD, Apraiz A, Izu R, Díaz-Pérez JL, Asumendi A. Nieto-Rementería N, et al. Among authors: izu r. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25. Br J Dermatol. 2009. PMID: 19067706
47 results